MedTrace Logo

Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®

NCT01608672 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2019-04-16

Study results available
· View outcomes & findings →

Summary

This is an observational study assessing patient satisfaction following at least 5 years of BOTOX® treatment for glabellar lines.

Conditions

  • Glabellar Lines

Interventions

BIOLOGICAL

botulinum toxin Type A

botulinum toxin Type A (BOTOX®) treatment to glabellar lines as prescribed by the Investigator over at least 5 years.

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-01
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States
  • Australia
  • Brazil
  • Canada
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01608672 on ClinicalTrials.gov